Name Jintanat Ananworanich Current Position



Download 88.74 Kb.
Page5/5
Date31.01.2017
Size88.74 Kb.
#12880
1   2   3   4   5

Ananworanich J, Ruxrungtham K, Sirivichayakul S, Ubolyam S, Jupimai T, Schutz M, Snowden W, Cooper D, Hirschel B and the Staccato Study Team. Resistance mutations in ARV-naïve patients treated with ritonavir-boosted saquinavir [Abstract WePe4.4C12]. 3rd IAS Conference on HIV Pathogenesis and Treatment. July 24-27, 2005, Rio de Janeiro

  • Ananworanich J, Sirivichayakul S, Ubolyam S, Chuenyam T, Schutz M, Snowden W, Cardiello P, Cooper D, Hirschel B, Ruxrungtham K. Different Incidence of Protease Resistance in Patients Failing Treatment on an Initial Ritonavir-Boosted Saquinavir (saquinavir/r) Regimen Versus Those With Prior Exposure to Dual-Nucleosides and Unboosted Saquinavir [Abstract 33]. International HIV Drug Resistance Workshop, June 7-10, 2005, Quebec

  • Ananworanich J, Kosalaraksa P, Siangphoe U, Hill A, Bergshoeff A, Pancharoen C, Engchanil C, Sankote J, Intasan J, Chuamchaitrakool A, Cooper D, Phanuphak P, Ruxrungtham K, Burger D. Pharmacokinetics and 24 week efficacy/safety of saquinavir/lopinavir/ritonavir in RTI pre-treated children [Abstract R-122]. 12th Conference on Retroviruses and Opportunistic Infections, February 22-25, 2005, Boston.

  • Duncombe, C.; Kerr S.J.; Avihingsanon, A; Ananworanich, J.; Boyd, M.; Sopa, B.; Cooper, D.; Lange, J. Phanuphak, P. Ruxrungtham, K. for the HIV-NAT Study Group.  Dyslipidaemia in an Asian Population Following Treatment for 2 Years with Five Different Protease Inhibitor Containing Regimens: The HIV-NAT Cohort.  12th Conference on Retroviruses and Opportunistic Infections.  February 22-25 2005. Boston

  • Ananworanich J, Apateerapong W, Siangphoe U, Ruxrungtham K, Hirschel B, Lange J, Cooper D, Phanuphak P. Post-clinical Trial Preference for CD4-guided versus continuous HAART in Thai patients previously randomized to CD4-guided treatment in a structured treatment interruption trial [Abstract TuPeB4563]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Nuesch R, Ananworanich J, Sirivichayakul S, Ubolyam S, Sangphoe U, Hill A, Lange J, Cooper D, Phanuphak P, Ruxrungtham K. Genotypic resistance after CD4 guided structured treatment interruption in HIV infected patients pre-treated with dual NRTI before HAART [Abstract TuPeB4562]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Ananworanich J, Siangphoe U, Cardiello P, Apateerapong W, Hirschel B, Srasuebkul P, Mahanontharit A, Ubolyam S, Hill A, Cooper D, Lange J, Phanuphak P, Ruxrungtham K. Comparing CD4-guided vs one week on - one week off vs continuous HAART in 74 patients with chronic HIV infection: week 108 results [Abstract WeOrB1283]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Ananworanich J, Ruxrungtham K, Siangphoe U, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Klinbuayam W, Tansuphasawadikul S, Nuesch R, Ubolyam S, Yakasem S, Hill A, Cooper D, Phanuphak P and Hirschel B. A Prospective Cohort Study of Efficacy and Safety of 2 NRTIs plus once-daily Ritonavir boosted-Saquinavir Hard Gel Capsule (SQV-HGC/r) at 24 weeks [Abstract TuPeB4469]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Ananworanich J, Wicharuk S, Siangphoe U, Ruxrungtham K, Prasithsirikul W, Chetchotisakd P, Kiertiburanakul S, Munsakul W, Klinbuayam W, Tansuphasawadikul S, Nuesch R, Ubolyam S, Yakasem S, Hill A, Cooper D, Hirschel B. Early savings through a strategy of CD4-guided treatment interruptions in Thailand [Abstract TuPeB4565].  XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Ananworanich J, Cheunyam T, Teeratakulpisarn S, Boyd MA, Ruxrungtham K, Lange J, Cooper D, Phanuphak P. Creating a drug fund to keep post-clinical trial patients on antiretroviral therapy: the HIV-NAT experience in Thailand [Abstract ThPeB7190]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Ananworanich J, Siripong A, Apateerapong W, Siangphoe U, Ubolyam S, Thisyakorn U, Ruxrungtham K, Lange J, Cooper D, Phanuphak P, Pancharoen P. Treatment outcome of two cohorts of Thai children treated with NNRTI-based HAART: children with baseline CD4 less than 15% and CD4 15-24% [Abstract TuPeB4403]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Ananworanich J, Apateerapong W, Siripong A, Chuamchaitrakool A, Thisyakorn U, Ruxrungtham K, Lange J, Cooper D,  Phanuphak P, Pancharoen C. Uptake and characteristics of children in the Thai Ministry of Public Health (MOPH) Pediatric Access to Care (PATC) Program at HIV-NAT/Chulalongkorn Pediatric Infectious Disease Clinic [Abstract TuPeB4402]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Lolekha R, Pancharoen C, Sirivichayakul S, Siangphoe U, Kaewchana S, Apateerapong W, Mahanontharit A, Chotpitayasunondh T, Ruxrungtham K, Ananworanich J. Incidence of reverse transcriptase genotypic mutations in children treated with dual nucleoside reverse transcriptase inhibitors: HIV-NAT 013 study [Abstract TuOrB1192]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Jupimai T, Wicharuk S, Ananworanich J, Siangphoe U, Apateerapong W. Mekmullica J, Sosothkul D, Chomchey N, Koekkoek S, Eggermont L, Cheunyam T, Phanuphak P, Pancharoen C. Behavioral and emotional problems in children with HIV infection compared to children with hematology/oncology diseases and children at a school setting [Abstract B10788]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Koekoek S, Eggermont L, Jupimai T, De Sonneville LMJ, Apateerapong W, Wicharuk S, Chomchey N, Pancharoen C, Cooper D, Lange J, Phanuphak P, Ananworanich J. The effects of highly active antiretroviral therapy (HAART) on neuropsychological functioning in Thai children with HIV disease [Abstract TuPeB4413]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Wicharuk S, Jupimai T, Siangphoe U, Pancharoen C, Apateerapong W, Chomchey N, Koekkoek S, Eggermont L, Samor T, Cheunyam T, Lange J, Cooper D, Phanuphak P, Ananworanich J. Stress and coping in caregivers of Thai children with HIV infection [TuPeB4418]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Apateerapong W, Pancharoen C, Eggermont L, Koekkoek S, Chuamchaitrakool A, Cheunyam T, Lange J, Cooper D, Phanuphak P, Ananworanich J. HIV disclosure in children [Abstract TuPeB4408]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Siripong A, Pancharoen C, Apateerapong W, Siangphoe U, Cheunyam T, Ruxrungtham K, Phanuphak P, Ananworanich J. Adherence in two pediatric Thai cohorts: children with baseline CD4 < 15% and children with CD4 15-24% [Abstract WePeB5776]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Siripong A, Pancharoen C, Kosalarksa P, Apateerapong W, Siangphoe U, Lumbiganon P, Engchanil C, Kamolirt S, Phanuphak P, Ananworanich J. Determining accurate methods of assessing adherence to HAART in Thai children [Abstract WePeB5778]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Siripong A, Pancharoen C, Apateerapong W, Ananworanich J. Understanding barriers to adherence to antiretroviral therapy in Thai children [Abstract ThPeD7847]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Siripong A, Pancharoen C, Chuamchaitrakool A, Apateerapong W, Ruxrungtham K, Phanuphak P, Ananworanich J. Improving adherence to ARV in Thai children using low-cost tools focusing on positive reinforcement [Abstract WePeB5779]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Tulloch O, Ananworanich J, Cardiello P, Morsbach K. Creating an environment for orphans with HIV infection to live in a loving and caring family setting and to receive highly active antiretroviral therapy (HAART) [Abstract WePeD6560]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Siripong A, Tulloch O, Boyd M, Morsbach K, Ananworanich J. Treatment outcome of non-nucleoside reverse transcriptase (NNRTI)-based highly active antiretroviral therapy (HAART) in orphans living in HIV-positive family-style Thai community [Abstract MoPeB3348]. XV International AIDS Conference, July 11 - 16, 2004, Bangkok.

  • Ananworanich J, Hill  A, Siangphoe U, Sankote J, Yakasem S, Burger D, Cooper D, Phanuphak P, Ruxrungtham K,  Hirschel B. Short-term HIV RNA reductions independent of Saquinavir Cmin - analysis of 72 Thai patients given Saquinavir/r with 2 NRTIs. 5th International Workshop on Clinical Pharmacology of HIV Therapy [Abstract 10.1].  April 1-3, 2004, Rome

  • Ananworanich J, Siangphoe U, Mahanontharit A, Hill A, Wicharuk S, Saenawat S, Burger D, Cooper D, Phanuphak P, Hirschel B, Ruxrungtham K. Saquinavir Cmin before and after switching NRTI to Tenofovir in patients treated with once daily saquinavir-hard gel capsule/ritonavir 1600 mg/100mg. 5th International Workshop on Clinical Pharmacology of HIV Therapy [Abstract 4.15].  April 1-3, 2004, Rome

  • Ananworanich J, Chantapakul H, Teeratakulpisarn S, Ubolyam S, Siangphoe U,  Ruxrungtham K.  IgE and allergic diseases in HIV-infected adults randomized to IL-2 and antiretrovirals (ARV) versus ARV alone [Abstract 381]. American Academy of Allergy, Asthma, and Immunology Annual Meeting, San Francisco. Accepted

  • Fagard C, Ananworanich J, Le Braz M, Perneger T, Perrin L, Cooper D, Cavassini M,  Ebnöther C, Genné D, Sukontha S, Wicharuk S, Ubolyam S, Vernazza P, Bernasconi E, Yerly S, Hirschel B. Biphasic Decline of CD4 Cell Count During Scheduled Treatment Interruptions (STIs). 11th Conference on Retroviruses and Opportunistic Infections [Abstract 568], February 8-11, 2004, San Francisco.

  • Autar RS, Ananworanich J, Apateerapong W, Sankote S, Hill A, Hirschel B, Cooper D, Lange J, Phanuphak P, Ruxrungtham K and Burger D.  Pharmacokinetic (pk) study of saquinavir hard gel caps/ritonavir (sqv-hgc/rtv) in hiv-1 infected patients: 1600/100 mg OD compared to 2000/100 MG OD and 1000/100 mg BID [Abstract poster 4.1/1]. 9th European AIDS Congress 25-29 October 2003. Warsaw

  • Ananworanich J, P. Cardiello, P. Srasuebkul, T. Samor, E. Hassink, A.  Mahanontharit, T. Boonmangum, W. Apateerapong, A. Hill, K. Ruxrungtham, D. Cooper, J. Lange, P. Phanuphak. HIV-NAT 001.4: A Prospective Randomized Trial of Structured Treatment Interruption (STI) in Patients with Chronic HIV Infection. 10th Conference of Retroviruses and Opportunistic Infections [Abstract 64], February 10 - 14, 2003, Boston.

  • Ananworanich J, Pancharoen C, Cardiello PG, Sudharmwat P, Apateerapong W, Boonmagnam T, Pongprayoon P, Srasuebkul P, Thisyakorn U, Phanuphak P. HIV-NAT 010: A randomized pilot study of immediate versus deferred antiretroviral therapy: week 24 data [Abstract 11B-02]. 1st Asian Congress of Pediatric Infectious Diseases, November 10 - 13, 2002, Pattaya

  • Cardiello P, Ananworanich J, Monhaphol T, Mahanontharit A, van Heeswijk R, Burger D, Ruxrungtham K, Lange J, Cooper D, Phanuphak P. Pharmacokinetics of once daily saquinavir-hard gel caps and saquinavir-soft gel caps boosted with ritonavir in HIV-1+ Thai patients [Abstract MoPpB 2007]. XIV International AIDS Conference, July 7 - 12, 2002, Barcelona.

  • Ananworanich J, Khongphatthanayothin M, Sirivichayakul S, Phanuphak P, Thisyakorn U. Thai red cross antiretrovirals donation program to prevent perinatal hiv transmission: comparison of zidovudine and zidovudine/nevirapine regimens [Abstract 100]. In Proceedings of the third Conference on Global Strategies for the prevention of HIV Transmission from Mothers to Infants, September 9 - 13, 2001, Kampala

  • Ananworanich J, Cardiello P, Worarien W, Ubolyam S, Phanuphak P, Ruxrungtham K. The Steady-state pharmacokinetics (PK) of saquinavir (SQV) with and without the addition of two doses of itraconazole in HIV-1-infected Thai patients: HIV-NAT 001.2 substudy, Pattaya, Thailand, April 24-27, 2001.  Internal Medicine 2001; 17:93(O95)

  • Gozum EG, Ananworanich J, Toutreddy B, Abramson SL. Prevalence and incidence of asthma among 136 primary immunodeficient patients at an allergy/immunology clinic. In Proceedings of the American Thoracic Society Annual Meeting, May 5-10, 2000, Toronto.

  • Ananworanich J, Lee B-N, Gao H, Shearer WT, Reuben J. Surface expression of CXCR4 and CCR5 on peripheral blood T lymphocytes and monocytes. In Proceedings of the Pediatric Academic Societies and American Academy of Pediatrics Joint Meeting, May 12-May16, 2000, Boston.

  • Ananworanich J, Lee B-N, Gao H, Shearer WT, Reuben J. Preincubation of T cells and monocytes with gp120 subsequently activated with PMA decreases cell surface expression of CXCR4.  May 12-May 16, 2000, Seattle. FASEB 2000;14:A937(39.23).

  • Ananworanich J, Shearer WT, Abramson SL. Drug-induced lupus erythematosus in a child with X-linked chronic granulomatous disease. American Academy of Allergy, Asthma, and Immunology Annual Meeting, March 3-March 8, 2000, San Diego. J Allergy Clin Immunol 2000;105:S340(105)

  • Gozum EG, Ananworanich J, Paul ME, Hanson IC, Rosenblatt HM. Different immunological profile in 2 sisters with combined immunodeficiency, lymphadenopathy and severe dermatitis. American Academy of Allergy, Asthma, and Immunology Annual Meeting, March 3-March 8, 2000, San Diego. J Allergy Clin Immunol 2000;105:S216(640)

  • Ananworanich J, Pacheco SE, Rosenblatt HM, Shearer WT, Hanson IC.  New combined immunodeficiency in an infant girl: normal CD3+ T cells, low CD4+ T cells, positive LPRs to some antigens, low CD20+ B cells, and qualitative/quantitative hypogammaglobulinemia: American Academy of Allergy, Asthma, and Immunology Annual Meeting, February 26-March 3, 1999, Orlando. J Allergy Clin Immunol 1999;103:S142(540).

  • Ananworanich J, Popek EJ, Hanson IC, Hammill HA, Shearer WT.  The relationship of placental HIV RNA and maternal antiretroviral therapy on perinatal transmission [abstract 237]. In Proceedings of the 6th Conference on Retroviruses and Opportunistic Infections, January 29 - February 5, 1999, Chicago.

  • Patterson B, Popek E, Ananworanich J, Siegal J, et al. Placentas express predominantly type 2 cytokines and CXCR4: significant downregulation of CXCR4 occurs in placentas from HIV-1 transmitting women [abstract 262]. In Proceedings of the 6th Conference on Retroviruses and Opportunistic Infections, January 29 - February 5, 1999, Chicago.

  • Ananworanich J, Krishnan V, Fan LL, Shearer WT, Rosenblatt HM. Meropenem immediate hypersensitivity skin testing in a cystic fibrosis (CF) patient [abstract 62].  In Proceedings from the American College of Allergy, Asthma, and Immunology Annual Meeting, Philadelphia, November 5-11, 1998.

  • Ananworanich J, Garrido D, Chintagumpala M, Hanson IC.  Successful desensitization in a child with type 1 hypersensitivity to carboplatin: a case report: American Academy of Allergy, Asthma and Immunology Annual Meeting, March 13-18, 1998, Washington, D.C. J Allergy Clin Immunol 1998; 101:S139 (577).



    Page of



    Download 88.74 Kb.

    Share with your friends:
  • 1   2   3   4   5




    The database is protected by copyright ©ininet.org 2022
    send message

        Main page